FDA ousts spokeswoman for exaggerating plasma therapy benefits for COVID-19 treatment

United States’ Food and drug ministration (FDA) has ousted its chief spokeswoman Emily Miller, days after ncy exaggerated benefits of experimental COVID rapy. Miller, who joined earlier this month, was apparently sacked due to lack of expertise in health care. According to international media reports, she still as a job at FDA, while White House, which appointed her, decides her employment status.

Re: US FDA Commissioner Apologises For Saying 'plasma Reduces COVID-19 Deaths By 35%'

Re: FDA Commissioner Says He Overstated Effects Of Virus rapy

Miller removed as OMA he

Before her appointment, Miller h experience in various government positions, stints at conservative media outlets, and work vocating for gun rights, but "little to health-care experience". An email which was circulated to employees of FDA revealed that Miller was longer he of OMA. While email thanked employees for ir “hard work”, it also said that ncy was working on alteration of team structure. ,

Meanwhile, FDA  Commissioner Stephen Hahn has apologized for exaggerating benefits of convalescent plasma rapy in treatment of critically ill, hospitalized COVID-19 patients. Hahn’s apology comes after a backlash from health experts and medical fraternity regarding President Donald Trump briefing wherein he called convalescent plasma as “breakthrough” and “life-saving”. Trump’s anuncement of its emergency authorization on eve of RNC has led many to suspect that move was “politically motivated”. Experts have raised objections on Hahn, overestimating a treatment with scientific evidence. 

“I have been criticized for remarks I me Sunday night about benefits of convalescent plasma,” Hahn said, taking to his official handle on Twitter. “ criticism is entirely justified. What I should have said better is that data show a relative risk reduction, t an absolute risk reduction,” Hahn ded. According to reports, re haven’t been any substantiated shreds of evidence about treatment massively curing coronavirus patients on support and larger risk.

Re: US FDA 'will Revoke Authorization' Of Plasma To Treat COVID 'if Needed', Says Chief

Re: Safdarjung Hospital To Restore OPD Services To rmal Timings From Tuesday